Clinical Trial Update: PP13 and Doppler Study to Predict Preeclampsia [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 clinical trial evaluating PP13 and Doppler ultrasound for predicting preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• PP13

Snippet

Sponsor: Ben-Gurion University of the Negev | Conditions: Preeclampsia | Phase 2, Phase 3 | Status: UNKNOWN